Europe Radiotherapy Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 2,176.99 Million |
 Market Size (Forecast Year) |
USD 3,890.91 Million |
 CAGR |
% |
| Major Markets Players |
|
Europe Radiotherapy Market, By Product & Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) - Industry Trends and Forecast to 2030.
Europe Radiotherapy Market Analysis and Size
The Europe incidence of cancer was on the rise, and radiotherapy is a crucial treatment modality for many cancer types. As the population continues to age and lifestyles change, the number of cancer cases was expected to increase, driving demand for radiotherapy. Increased awareness about cancer and its treatment options, along with improved screening and early detection methods, led to more individuals seeking cancer treatments, including radiotherapy. In many countries, healthcare spending has been increasing, providing more funding for advanced treatments like radiotherapy. Governments and private healthcare providers have been investing in upgrading their facilities and equipment.
Data Bridge Market Research analyzes that the radiotherapy market is expected to reach the value of USD 3,890.91 million by 2030, from USD 2,176.99 million in 2022, growing at a CAGR of 7.9% during the forecast period.
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Product & Services (Services, Product, and Software), Type (External-Beam Radiation Therapy, Internal Radiation Therapy, Systemic Radiotherapy/ Radiopharmaceuticals, and Others), Application (Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Lymphoma, Liver Cancer, Thyroid Cancer, Brain Cancer, Cervical Cancer, Spine Cancer, and Others), End User (Hospitals, Radiation Therapy Centers, Specialty Clinics, and Others), Distribution Channel (Direct Tenders, Third Party Distributors, and Others) |
|
Countries Covered |
Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Sweden, and Rest of Europe |
|
Market Players Covered |
Siemens Healthcare GmbH, Elekta, Accuray Incorporated, General Electric Company, IBA Worldwide, Koninklijke Philips N.V., Hitachi, Ltd. , CANON MEDICAL SYSTEMS CORPORATION, Nordion Inc. (A Subsidiary of Sotera Health), Mevion Medical Systems, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”), Brainlab, ZEISS International, BEBIG Medical., SHINVA MEDICAL INSTRUMENT CO., LTD., LinaTech, Inc., and United Imaging Healthcare Co., Ltd., among others |
Market Definition
Radiotherapy is a type of treatment procedure that is mainly used for the treatment of cancer disease by the usage of X-rays along with similar forms of radiation technology. In radiotherapy treatment, high-energy-based radiation rays are often used to damage cancer cells and stop them from growing and dividing. Various types of software such as treatment planning software, dosage planning software, patient positioning software, image guiding software, and systemic radiotherapy among others are used in radiotherapy treatment planning. The treatment software program is used to calculate the dose of radiation which will be delivered to the patient's tumor and the surrounding normal tissue.
Europe Radiotherapy Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail below:
Drivers
- Growing prevalence of cancer disease
The Europe incidence of cancer continues to rise due to factors such as aging populations, lifestyle changes, environmental factors, and increased cancer awareness and screening. The demand for effective treatment options such as radiotherapy grows as more individuals are diagnosed with cancer. Radiotherapy can be used as a primary treatment for cancer, especially in cases where surgery is not feasible or as effective. It can also be used in conjunction with surgery, chemotherapy, or immunotherapy to enhance treatment outcomes. The versatility of radiotherapy makes it an essential tool in the comprehensive cancer treatment arsenal.
Statistics on cancer describe that large groups of people have cancer across the world. Statistics show things that many people died from cancer each year. The treatment of radiotherapy can cure cancer symptoms. Radiation therapy uses high-energy particles or waves to kill the symptoms of cancer. Several people who are currently living with cancer require radiotherapy for cancer treatment. For this reason, the growing prevalence of cancer disease is acting as a driver for increasing the demand for the market.
- Novel technology in radiotherapy for cancer treatment
During the past several years, cancer radiotherapy has been largely driven by technological development. The technological development in radiotherapy is mainly focused on improving therapy procedures and launching new products which have advanced features that help in the treatment of cancer patients. This special issue aims at novel technological developments and has large potential in improving patient safety and treatment outcome in the radiotherapy management of cancers worldwide.
The modern and advanced technology-based radiotherapy procedure comprises the use of three-dimensional (3D) imaging technology, high-energy x-ray machines, and computerized treatment planning, which enhances the chances for more precise treatment possible. The increasing number of patients who successfully use radiation therapy due to technological advancement in radiotherapy and novel technology in radiotherapy for cancer treatment is expected to drive market growth.
Opportunity
- Increasing healthcare expenditure for cancer treatment
The government is continuously engaged in the activity of improving healthcare facilities to provide better health facilities and treatment to the patients such as improving cancer treatment procedures and increasing the number of radiotherapy treatment providers, among others. Growing healthcare expenditure is an opportunity for the market, because if investment in healthcare increases more people are getting aware of cancer disease and undergo advanced technology-based cancer treatment.
Continuously increasing healthcare expenditure help the end user to install the latest technology-based radiotherapy systems to improve efficiency, accuracy, and number of successful radiotherapy cancer treatments.
Restraint/Challenge
- Lack of skilled and certified professionals
Radiotherapy is a type of complex procedure, operated by highly advanced radiotherapy products which deliver radiation explorer to a targeted point of the patient body to destroy the cancer cells. The radiotherapy procedure requires highly skilled and certified professionals as in this procedure, healthcare professionals have to decide the dosages of radiation delivered to the patient's body with the help of treatment planning software. Healthcare professionals need to be aware of how to handle these software and therapy modalities. The requirement for skilled and certified professionals is a big restraint for the market. The demand for cancer treatment is increasing due to continuously increasing cases of cancer disease across the world but a lack of skilled and certified professionals hampering the growth of the market.
Recent Developments
- In June 2023, Merit Medical Systems. acquired Bluegrass Vascular’s Surfacer Inside-Out Access Catheter System. This has helped the company to generate more revenues
- In June 2023, Sonablate Corp. was recognized as one of CEO View’s top 10 healthcare companies of the year 2023. This has helped the company to establish its presence in the europe radiotherapy market
- In November 2022, Terumo Europe NV announced that it welcomed the positive guidance released by the National Institute for Health and Care Excellence (NICE), mentioning that microwave ablation can be used provided standard arrangements are in place for clinical governance, consent, and audit. This is positive news as it broadens access to minimally invasive alternatives to surgery available to patients with symptomatic benign thyroid nodules
- In July 2022, EDAP TMS announced Focal One HIFU reimbursement raised to urology APC Level 6 under CMS Outpatient Prospective Payment System (OPPS) Proposed Rule for CY23. This has helped the company to establish its Europe presence
- In July 2021, Bioventus LLC. and Misonix announced definitive agreement for Bioventus to acquire Misonix. This has helped the company to strengthen its product portfolio
Europe Radiotherapy Market Scope
The radiotherapy market is segmented into five notable segments such as product & services, type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product & Services
- Services
- Product
- Software
On the basis of product & services, the market is segmented into services, product, and software.
Type
- External-Beam Radiation Therapy
- Internal Radiation Therapy
- Systemic Radiotherapy/ Radiopharmaceuticals
- Others
On the basis of type, the market is segmented into external-beam radiation therapy, internal radiation therapy, systemic radiotherapy/ radiopharmaceuticals, and others.
Application
- Breast Cancer
- Lung Cancer
- Prostate Cancer
- Colorectal Cancer
- Lymphoma
- Liver Cancer
- Thyroid Cancer
- Brain Cancer
- Cervical Cancer
- Spine Cancer
- Others
On the basis of application, the market is segmented into breast cancer, lung cancer, prostate cancer, colorectal cancer, lymphoma, liver cancer, thyroid cancer, brain cancer, cervical cancer, spine cancer, and others.
End User
- Hospitals
- Radiation Therapy Centers
- Specialty Clinics
- Others
On the basis of end user, the market is segmented into hospitals, radiation therapy centers, specialty clinics, and others.
Distribution Channel
- Direct Tenders
- Third Party Distributors
- Others
On the basis of distribution channel, the market is segmented into direct tenders, third party distributors, and others.
Europe Radiotherapy Market Regional Analysis/Insights
The radiotherapy market is analyzed and market size insights and trends are provided by country, product & services, type, application, end user, and distribution channel as referenced above.
The countries covered in this market report are Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, Sweden, and Rest of Europe.
Germany is expected to dominate the market due to the higher level of investments by various manufacturers and increasing demand for radiotherapy in the country.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends, porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Europe Radiotherapy Market Share Analysis
The radiotherapy market competitive landscape provides details of the competitor. Details included are company overview, company financials, revenue generated, market potential, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major market players operating in the radiotherapy market are Siemens Healthcare GmbH, Elekta, Accuray Incorporated, General Electric Company, IBA Worldwide, Koninklijke Philips N.V., Hitachi, Ltd. , CANON MEDICAL SYSTEMS CORPORATION, Nordion Inc. (A Subsidiary of Sotera Health), Mevion Medical Systems, Eckert & Ziegler BEBIG, VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”), Brainlab, ZEISS International, BEBIG Medical., SHINVA MEDICAL INSTRUMENT CO., LTD., LinaTech, Inc., and United Imaging Healthcare Co., Ltd., among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE EUROPE RADIOTHERAPY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT AND SERVICES SEGMENT LIFELINE CURVE
2.8 MARKET END USERS COVERAGE GRID
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES MODEL
5 REGULATORY GUIDELINES FOR RADIOTHERAPY
5.1 EUROPE REGULATORY GUIDELINE FOR RADIOTHERAPY
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 GROWING PREVALENCE OF CANCER DISEASE
6.1.2 NOVEL TECHNOLOGY IN RADIOTHERAPY FOR CANCER TREATMENT
6.1.3 INCREASING ADOPTION OF RADIOTHERAPY DEVICES AND PROCEDURES
6.1.4 RISING PREFERENCE FOR NON-SURGICAL PROCEDURES
6.2 RESTRAINTS
6.2.1 LACK OF SKILLED AND CERTIFIED PROFESSIONALS
6.2.2 HIGH COST OF TREATMENT AND RADIOTHERAPY PROCEDURE
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE FOR CANCER TREATMENT
6.3.2 GROWING GOVERNMENT INITIATIVES TOWARD CANCER TREATMENT
6.3.3 RISING PATIENTS AWARENESS TOWARDS CANCER TREATMENT
6.4 CHALLENGES
6.4.1 STRICT REGULATIONS AND STANDARDS FOR APPROVAL AND COMMERCIALIZATION OF RADIOTHERAPY PRODUCTS
6.4.2 RISK OF RADIATION EXPOSURE
7 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES
7.1 OVERVIEW
7.2 SERVICES
7.3 PRODUCT
7.3.1 EXTERNAL BEAM RADIOTHERAPY
7.3.1.1 LINAC
7.3.1.2 PROTON THERAPY
7.3.1.2.1 SYNCHROTRON
7.3.1.2.2 CYCLOTRON
7.3.1.3 CYBER KNIFE
7.3.1.4 GAMMA KNIFE
7.3.1.5 OTHERS
7.3.2 INTERNAL RADIATION RADIOTHERAPY
7.3.2.1 SEEDS
7.3.2.2 ELECTRONIC BRACHYTHERAPY
7.3.2.3 APPLICATORS
7.3.2.4 AFTERLOADERS
7.3.2.5 OTHERS
7.3.3 SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS
7.3.3.1 ALPHA EMITTERS
7.3.3.2 BETA EMITTERS
7.3.3.3 OTHERS
7.4 SOFTWARE
7.4.1 IMAGE GUIDING SOFTWARE
7.4.2 TREATMENT PLANNING SOFTWARE
7.4.3 PATIENT POSITIONING SOFTWARE
7.4.4 DOSAGE PLANNING SOFTWARE
7.4.5 OTHERS
8 EUROPE RADIOTHERAPY MARKET, BY TYPE
8.1 OVERVIEW
8.2 EXTERNAL-BEAM RADIATION THERAPY
8.2.1 IMAGE-GUIDED RADIATION THERAPY (IGRT)
8.2.2 PROTON BEAM THERAPY
8.2.3 STEREOTACTIC RADIATION THERAPY
8.2.4 INTENSITY MODULATED RADIATION THERAPY (IMRT)
8.2.5 THREE-DIMENSIONAL CONFORMAL RADIATION THERAPY (3D-CRT)
8.2.6 VOLUMETRIC MODULATED ARC THERAPY (VMAT)
8.2.7 OTHERS
8.3 INTERNAL RADIATION THERAPY
8.3.1 BRACHYTHERAPY
8.3.2 INTRAOPERATIVE RADIATION THERAPY (IORT)
8.3.3 OTHERS
8.4 SYSTEMIC RADIOTHERAPY/ RADIOPHARMACEUTICALS
8.5 OTHERS
9 EUROPE RADIOTHERAPY MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 BREAST CANCER
9.3 LUNG CANCER
9.4 PROSTATE CANCER
9.5 COLORECTAL CANCER
9.6 LYMPHOMA
9.7 LIVER CANCER
9.8 THYROID CANCER
9.9 BRAIN CANCER
9.1 CERVICAL CANCER
9.11 SPINE CANCER
9.12 OTHERS
10 EUROPE RADIOTHERAPY MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 RADIATION THERAPY CENTERS
10.4 SPECIALTY CLINICS
10.5 OTHERS
11 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDERS
11.3 THIRD PARTY DISTRIBUTORS
11.4 OTHERS
12 EUROPE RADIOTHERAPY MARKET, BY COUNTRY
12.1 GERMANY
12.2 FRANCE
12.3 U.K.
12.4 ITALY
12.5 SPAIN
12.6 RUSSIA
12.7 TURKEY
12.8 BELGIUM
12.9 NETHERLANDS
12.1 SWITZERLAND
12.11 SWEDEN
12.12 REST OF EUROPE
13 EUROPE RADIOTHERAPY MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: EUROPE
14 SWOT ANALYSIS
15 COMPANY PROFILES
15.1 ELEKTA
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 PRODUCT PORTFOLIO
15.1.4 RECENT DEVELOPMENTS
15.2 GENERAL ELECTRIC COMPANY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 PRODUCT PORTFOLIO
15.2.4 RECENT DEVELOPMENT
15.3 SIEMENS HEALTHCARE GMBH
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 PRODUCT PORTFOLIO
15.3.4 RECENT DEVELOPMENT
15.4 HITACHI, LTD.
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 PRODUCT PORTFOLIO
15.4.4 RECENT DEVELOPMENT
15.5 KONINKLIJKE PHILIPS N.V.
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 PRODUCT PORTFOLIO
15.5.4 RECENT DEVELOPMENT
15.6 ACCURACY INCORPORATED
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUE ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENT
15.7 BEBIG MEDICAL.
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENT
15.8 BRAINLAB
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENTS
15.9 CANON MEDICAL SYSTEMS CORPORATION
15.9.1 COMPANY SNAPSHOT
15.9.2 REVENUE ANALYSIS
15.9.3 PRODUCT PORTFOLIO
15.9.4 RECENT DEVELOPMENT
15.1 ECKERT & ZIEGLER BEBIG
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 IBA WORLDWIDE
15.11.1 COMPANY SNAPSHOT
15.11.2 REVENUE ANALYSIS
15.11.3 PRODUCT PORTFOLIO
15.11.4 RECENT DEVELOPMENT
15.12 LINATECH INC
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENT
15.13 MEVION MEDICAL SYSTEMS
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.14 NORDION (CANADA) INC. (A SUBSIDIARY OF SOTERA HEALTH)
15.14.1 COMPANY SNAPSHOT
15.14.2 PRODUCT PORTFOLIO
15.14.3 RECENT DEVELOPMENT
15.15 SHINVA MEDICAL INSTRUMENT CO., LTD.
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 UNITED IMAGING HEALTHCARE CO., LTD
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 VIEWRAY TECHNOLOGIES, INC. (“VIEWRAY”)
15.17.1 COMPANY SNAPSHOT
15.17.2 REVENUE ANALYSIS
15.17.3 PRODUCT PORTFOLIO
15.17.4 RECENT DEVELOPMENT
15.18 ZEISS INTERNATIONAL
15.18.1 COMPANY SNAPSHOT
15.18.2 REVENUE ANALYSIS
15.18.3 PRODUCT PORTFOLIO
15.18.4 RECENT DEVELOPMENT
16 QUESTIONNAIRE
17 RELATED REPORTS
List of Table
TABLE 1 EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 2 EUROPE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 3 EUROPE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 4 EUROPE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 5 EUROPE INTERNAL RADIATION RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 6 EUROPE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 7 EUROPE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 8 EUROPE RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 EUROPE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 EUROPE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 EUROPE RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 12 EUROPE RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 13 EUROPE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 14 EUROPE RADIOTHERAPY MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 15 GERMANY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 16 GERMANY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 17 GERMANY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 18 GERMANY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 19 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 20 GERMANY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 21 GERMANY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 22 GERMANY RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 23 GERMANY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 24 GERMANY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 GERMANY RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 26 GERMANY RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 27 GERMANY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 28 FRANCE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 29 FRANCE PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 30 FRANCE EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 31 FRANCE PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 32 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 33 FRANCE SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 34 FRANCE SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 35 FRANCE RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 36 FRANCE EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 37 FRANCE INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 FRANCE RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 39 FRANCE RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 40 FRANCE RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 41 U.K. RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 42 U.K. PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 43 U.K. EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 44 U.K. PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 45 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 46 U.K. SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 47 U.K. SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 48 U.K. RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 49 U.K. EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 50 U.K. INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 U.K. RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 52 U.K. RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 53 U.K. RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 54 ITALY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 55 ITALY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 56 ITALY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 57 ITALY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 58 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 59 ITALY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 60 ITALY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 61 ITALY RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 62 ITALY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 63 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 ITALY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 65 ITALY RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 66 ITALY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 67 SPAIN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 68 SPAIN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 69 SPAIN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 70 SPAIN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 71 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 72 SPAIN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 73 SPAIN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 74 SPAIN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 SPAIN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 SPAIN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 SPAIN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 78 SPAIN RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 SPAIN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 80 RUSSIA RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 81 RUSSIA PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 82 RUSSIA EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 83 RUSSIA PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 84 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 85 RUSSIA SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 86 RUSSIA SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 87 RUSSIA RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 RUSSIA EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 89 RUSSIA INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 90 RUSSIA RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 91 RUSSIA RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 92 RUSSIA RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 93 TURKEY RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 94 TURKEY PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 95 TURKEY EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 96 TURKEY PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 97 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 98 TURKEY SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 99 TURKEY SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 100 TURKEY RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 TURKEY EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 TURKEY INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 TURKEY RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 104 TURKEY RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 105 TURKEY RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 106 BELGIUM RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 107 BELGIUM PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 108 BELGIUM EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 109 BELGIUM PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 110 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 111 BELGIUM SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 112 BELGIUM SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 113 BELGIUM RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 114 BELGIUM EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 115 BELGIUM INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 116 BELGIUM RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 117 BELGIUM RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 118 BELGIUM RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 119 NETHERLANDS RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 120 NETHERLANDS PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 121 NETHERLANDS EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 122 NETHERLANDS PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 123 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 124 NETHERLANDS SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 125 NETHERLANDS SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 126 NETHERLANDS RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 NETHERLANDS EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 NETHERLANDS INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 129 NETHERLANDS EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 130 NETHERLANDS RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 131 NETHERLANDS RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 132 SWITZERLAND RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 133 SWITZERLAND PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 134 SWITZERLAND EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 135 SWITZERLAND PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 136 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 137 SWITZERLAND SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 138 SWITZERLAND SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 139 SWITZERLAND RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 140 SWITZERLAND EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 141 SWITZERLAND INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 142 SWITZERLAND RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 143 SWITZERLAND RADIOTHERAPY MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 144 SWITZERLAND RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 145 SWEDEN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 146 SWEDEN PRODUCT IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 147 SWEDEN EXTERNAL BEAM RADIOTHERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 148 SWEDEN PROTON THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 149 SWEDEN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 150 SWEDEN SYSTEMIC RADIOTHERAPY/RADIOPHARMACEUTICALS IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 151 SWEDEN SOFTWARE IN RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
TABLE 152 SWEDEN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 153 SWEDEN EXTERNAL-BEAM RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 154 SWEDEN INTERNAL RADIATION THERAPY IN RADIOTHERAPY MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 155 SWEDEN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 156 SWEDEN RADIOTHERAPY MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 157 SWEDEN RADIOTHERAPY MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 158 REST OF EUROPE RADIOTHERAPY MARKET, BY PRODUCT & SERVICES, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 EUROPE RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 2 EUROPE RADIOTHERAPY MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE RADIOTHERAPY MARKET: DROC ANALYSIS
FIGURE 4 EUROPE RADIOTHERAPY MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE RADIOTHERAPY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE RADIOTHERAPY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE RADIOTHERAPY MARKET: MARKET END USERS COVERAGE GRID
FIGURE 8 EUROPE RADIOTHERAPY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 EUROPE RADIOTHERAPY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 EUROPE RADIOTHERAPY MARKET: SEGMENTATION
FIGURE 11 THE RISING PREVALENCE OF CANCER AND GROWING DEMAND FOR MINIMALLY INVASIVE PROCEDURES ARE EXPECTED TO DRIVE THE GROWTH OF THE EUROPE RADIOTHERAPY MARKET FROM 2023 TO 2030
FIGURE 12 THE PRODUCT AND SERVICES SEGMENT, IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE RADIOTHERAPY MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITY AND CHALLENGES FOR EUROPE RADIOTHERAPY MARKET
FIGURE 14 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2022
FIGURE 15 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, 2023-2030 (USD MILLION)
FIGURE 16 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, CAGR (2023-2030)
FIGURE 17 EUROPE RADIOTHERAPY MARKET: BY PRODUCT & SERVICES, LIFELINE CURVE
FIGURE 18 EUROPE RADIOTHERAPY MARKET: BY TYPE, 2022
FIGURE 19 EUROPE RADIOTHERAPY MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 20 EUROPE RADIOTHERAPY MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 21 EUROPE RADIOTHERAPY MARKET: BY TYPE, LIFELINE CURVE
FIGURE 22 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, 2022
FIGURE 23 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 24 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 25 EUROPE RADIOTHERAPY MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 EUROPE RADIOTHERAPY MARKET: BY END USER, 2022
FIGURE 27 EUROPE RADIOTHERAPY MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 28 EUROPE RADIOTHERAPY MARKET: BY END USER, CAGR (2023-2030)
FIGURE 29 EUROPE RADIOTHERAPY MARKET: BY END USER LIFELINE CURVE
FIGURE 30 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 31 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 32 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 33 EUROPE RADIOTHERAPY MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 34 EUROPE RADIOTHERAPY MARKET: SNAPSHOT (2022)
FIGURE 35 Europe Radiotherapy Market: Company Share 2022 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
